期刊文献+

Osterix在调控脊椎松质骨骨量中的作用 被引量:1

The role of Osterix in controlling bone volume in vertebral body
暂未订购
导出
摘要 目的观察Osterix在调控脊椎松质骨骨量的作用及机制。方法以Osterix敲除小鼠和Osterix转基因小鼠为观察对象,采用X线摄像、显微电子计算机X线断层摄影术(Micro-CT)和苏木素-伊红(HE)染色观察Osterix过表达或敲除后小鼠腰椎骨量的变化,抗酒石酸酸性磷酸酶(TRAP)染色观察破骨细胞的变化。免疫组织化学检测核因子-κB受体活化因子配体(RANKL)表达情况的变化。结果 Osterix转基因小鼠腰椎骨量没有明显变化,而X线片、Micro-CT和HE染色检测显示Osterix敲除小鼠在出生后12周脊椎密度和骨量增加;TRAP染色显示腰椎中破骨细胞数量减少;免疫组织化学染色检测显示其椎体中RANKL表达水平降低。结论 Osterix在调控脊椎松质骨骨量中起到重要作用。 Objective To observe the role of Osterix in controlling bone volume in vertebral body and to investigate the possible mechanism .Methods X-ray radiology ,micro CT and HE staining were used to evaluate the change of bone volume in both Osterix knockout and transgenic mice .TRAP staining was used to assess the activity of osteoclasts and immunohistochemistry was used to examine the expression level of RANKL .Results No obvious changes were found in Osterix transgenic mice ,while X-ray examina-tion ,micro CT and HE staining showed that the bone density and bone volume in the lumbar vertebral body increased significantly in OSX null mice 12 weeks after birth .TRAP staining showed that the number of osteoclasts decreased in OSX null mice .IHC re-vealed that the expression level of RANKL was down-regualted in OSX null mice .Conclusion Osterix play an important role in controlling bone volume of vertebral body in mice .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第4期385-387,共3页 Chongqing medicine
基金 创伤 烧伤与复合伤国家重点实验室自主课题(SKLZZ201124) "十二五"科研项目重大项目分课题(AWS11J008) 国家自然基金面上项目(81271935)
关键词 脊柱 骨量 Osterix spine Osterix bone volume
  • 相关文献

参考文献17

  • 1Baron R.Osteoporosis in 2011:Osteoporosis therapy-dawn of the post-bisphosphonate era[J].Nat Rev Endo-crinol,2011,8(2):76-78.
  • 2Landete-Castillejos T,Molina-Quilez I,Estevez JA,et al.Alternative hypothesis for the origin of osteoporosis:therole of Mn[J].Front Biosci(Elite Ed),2012,4:1385-1389.
  • 3Brandi ML.An overview of osteoporosis:from genetics toclinics[J].Aging Clin Exp Res,2011,23(2 Suppl):3-5.
  • 4Nakashima K,Zhou X,Kunkel G,et al.The novel zinc fin-gercontaining transcription factor osterix is required forosteoblast differentiation and bone formation[J].Cell,2002,108(1):17-29.
  • 5Baek WY,de Crombrugghe B,Kim JE.Postnatally in-duced inactivation of Osterix in osteoblasts results in thereduction of bone formation and maintenance[J],Bone,2010,46(4):920-928.
  • 6Zhou X,Zhang Z,Feng JQ,et al.Multiple functions ofOsterix are required for bone growth and homeostasis inpostnatal mice[J].Proc Natl Acad Sci U S A,2010,107(29):12919-12924.
  • 7van den Bergh JP,van Geel TA,Geusens PP.Osteoporo-sis,frailty and fracture:implications for case finding andtherapy[J].Nat Rev Rheumatol,2012,8(3):163-172.
  • 8陈隽,李裕华,张莉萍,邱同凤,彭辉,邓忠良,王玉君,严钟德.重庆地区骨质疏松症维生素D受体基因与骨密度关系的初探[J].重庆医学,2003,32(7):881-882. 被引量:5
  • 9Davison KS,Siminoski K,Adachi JD,et al.Bone strength:the whole is greater than the sum of its parts[J],SeminArthritis Rheum,2006,36(1):22-31.
  • 10Friedman AW.Important determinants of bone strength:beyond bone mineral density[J].J Clin Rheumatol,2006,12⑵:70-77.

二级参考文献73

共引文献27

同被引文献13

引证文献1

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部